Search research articles
Contact Us
Filters
Showing results (11-20 of 81) with videos related to
Page
of 9
Sort By:
Cancer Research
|
November 1, 1986
Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells
G Capranico, C Soranzo, F Zunino
Life Sciences
|
January 1, 1991
The role of topoisomerase II in drug resistance
P De Isabella, G Capranico, F Zunino
Nucleic Acids Research
|
August 23, 2000
Loss of drug-stimulated topoisomerase II DNA breaks in living cells is different at two unrelated loci
M Binaschi, M E Borgnetto, G Capranico
Nucleic Acids Research
|
January 25, 1995
Base sequence determinants of amonafide stimulation of topoisomerase II DNA cleavage
P De Isabella, F Zunino, G Capranico
Nucleic Acids Research
|
November 25, 1990
Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin
G Capranico, K W Kohn, Y Pommier
Molecular Pharmacology
|
October 1, 1996
Aza-bioisosteres of 9, 10-anthracenedione: a modulation of DNA sequence specificity
C Sissi, G Capranico, E Menta, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
September 1, 1992
Current approaches to new drug development in cancer chemotherapy
F Zunino, G Capranico, G Pratesi, et al.
The Journal of Biological Chemistry
|
October 7, 1994
Unique sequence specificity of topoisomerase II DNA cleavage stimulation and DNA binding mode of streptonigrin
G Capranico, M Palumbo, S Tinelli, et al.
Anti-Cancer Drugs
|
December 1, 1994
Topoisomerase I gene expression and cell sensitivity to camptothecin in human cell lines of different tumor types
P Perego, G Capranico, R Supino, et al.
Journal of Molecular Biology
|
January 8, 1999
Genomic sites of topoisomerase II activity determined by comparing DNA breakage enhanced by three distinct poisons
M E Borgnetto, S Tinelli, L Carminati, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 81) with videos related to
Sort By:
Page
of 9
Cancer Research
|
November 1, 1986
Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells
G Capranico, C Soranzo, F Zunino
Life Sciences
|
January 1, 1991
The role of topoisomerase II in drug resistance
P De Isabella, G Capranico, F Zunino
Nucleic Acids Research
|
August 23, 2000
Loss of drug-stimulated topoisomerase II DNA breaks in living cells is different at two unrelated loci
M Binaschi, M E Borgnetto, G Capranico
Nucleic Acids Research
|
January 25, 1995
Base sequence determinants of amonafide stimulation of topoisomerase II DNA cleavage
P De Isabella, F Zunino, G Capranico
Nucleic Acids Research
|
November 25, 1990
Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin
G Capranico, K W Kohn, Y Pommier
Molecular Pharmacology
|
October 1, 1996
Aza-bioisosteres of 9, 10-anthracenedione: a modulation of DNA sequence specificity
C Sissi, G Capranico, E Menta, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
September 1, 1992
Current approaches to new drug development in cancer chemotherapy
F Zunino, G Capranico, G Pratesi, et al.
The Journal of Biological Chemistry
|
October 7, 1994
Unique sequence specificity of topoisomerase II DNA cleavage stimulation and DNA binding mode of streptonigrin
G Capranico, M Palumbo, S Tinelli, et al.
Anti-Cancer Drugs
|
December 1, 1994
Topoisomerase I gene expression and cell sensitivity to camptothecin in human cell lines of different tumor types
P Perego, G Capranico, R Supino, et al.
Journal of Molecular Biology
|
January 8, 1999
Genomic sites of topoisomerase II activity determined by comparing DNA breakage enhanced by three distinct poisons
M E Borgnetto, S Tinelli, L Carminati, et al.
Page
of 9